1. Umeclidinium Plus Vilanterol Versus Placebo, Umeclidinium, or Vilanterol Monotherapies for Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials

   • Li Wang
   • Chun-juan Zhai
   • Shu-juan Jiang

   Systematic Review 18 August 2016 Pages: 865 - 875

   

2. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions

   • Setsuro Ogawa
   • Akio Arakawa
   • Tamotsu Yoshiyama

   Original Research Article 22 July 2016 Pages: 877 - 888

   

3. Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus

   • Qian Zhao
   • Xia Chen
   • Pei Hu

   Original Research Article 18 July 2016 Pages: 889 - 902

   

4. Pharmacokinetic Profile and Palatability of Atomoxetine Oral Solution in Healthy Japanese Male Adults

   • Masako Nakano
   • Jennifer Witcher
   • Taro Goto

   Original Research Article Open access 21 July 2016 Pages: 903 - 911

   

5. Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers

   • Maria Rosario
   • Timothy Wyant
   • Brian G. Feagan

   Original Research Article 15 July 2016 Pages: 913 - 923

   

6. Hypersensitivity Events, Including Potentially Hypersensitivity-Related Skin Events, with Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis

   • Annika Mellander
   • Martin Billger
   • Kristina Johnsson

   Original Research Article 26 July 2016 Pages: 925 - 933

   

7. Safety Assessment of Liver Injury with Quetiapine Fumarate XR Management in Very Heavy Drinking Alcohol-Dependent Patients

   • Vatsalya Vatsalya
   • Akash Pandey
   • Craig J. McClain

   Original Research Article 08 August 2016 Pages: 935 - 944

   

8. A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence

   • Philippe Laramée
   • Aurélie Millier
   • Jürgen Rehm

   Original Research Article 28 July 2016 Pages: 945 - 956

   

9. Comparison of Effectiveness Between Delamanid and Bedaquiline Among Patients with Multidrug-Resistant Tuberculosis: A Markov Model Simulation Study

   • Ji-Hye Byun
   • Jae-A Park
   • Eui-Kyung Lee

   Original Research Article 27 July 2016 Pages: 957 - 968

   

10. Hydrocodone Bitartrate ER (Hysingla^® ER): A Review in Chronic Pain

    • Sohita Dhillon

    Adis Drug Evaluation 07 October 2016 Pages: 969 - 980